Genetic and environmental pathways to complex diseases

[1]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[2]  Geffrey F. Stopper,et al.  Choosing the right path: enhancement of biologically relevant sets of genes or proteins using pathway structure , 2009, Genome Biology.

[3]  Victor Chan,et al.  Subtoxic chlorpyrifos treatment resulted in differential expression of genes implicated in neurological functions and development , 2009, Archives of Toxicology.

[4]  Thomas C. Wiegers,et al.  Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical–gene–disease networks , 2008, Nucleic Acids Res..

[5]  M. Dalgaard,et al.  Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. , 2008, Toxicology.

[6]  E. Ros,et al.  Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment. , 2008, Pharmacogenomics.

[7]  Jeffrey D. Zaremba,et al.  Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo , 2008, Proceedings of the National Academy of Sciences.

[8]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[9]  L. Nguyen,et al.  Characterization of the proneural gene regulatory network during mouse telencephalon development , 2008, BMC Biology.

[10]  A. Look,et al.  Mechanisms of transcription factor deregulation in lymphoid cell transformation , 2007, Oncogene.

[11]  Division on Earth.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2007 .

[12]  M. Fielden,et al.  A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Stephen T Warren,et al.  Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. , 2007, Human molecular genetics.

[14]  S. Kasif,et al.  Network-Based Analysis of Affected Biological Processes in Type 2 Diabetes Models , 2007, PLoS genetics.

[15]  J. Berger,et al.  Retinaldehyde represses adipogenesis and diet-induced obesity , 2007, Nature Medicine.

[16]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[17]  M. Lazar,et al.  A Widely Used Retinoic Acid Receptor Antagonist Induces Peroxisome Proliferator-Activated Receptor-γ Activity , 2007, Molecular Pharmacology.

[18]  J. Connell,et al.  The link between abdominal obesity, metabolic syndrome and cardiovascular disease. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[19]  Harlan M Krumholz,et al.  Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. , 2007, JAMA.

[20]  Christa S Merzdorf,et al.  Emerging roles for zic genes in early development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[21]  V. McKusick.  Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.

[22]  A. Pession,et al.  N − 3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implications in cardiac hypertrophy and heart failure , 2007, FEBS letters.

[23]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[24]  Daniel G. Tenen,et al.  Transcription factors in myeloid development: balancing differentiation with transformation , 2007, Nature Reviews Immunology.

[25]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[26]  M. Shelby.  NTP-CERHR monograph on the potential human reproductive and developmental effects of di (2-ethylhexyl) phthalate (DEHP). , 2006, NTP CERHR MON.

[27]  K. Clément,et al.  Review article: Is obesity an inflammatory illness? Role of low‐grade inflammation and macrophage infiltration in human white adipose tissue , 2006 .

[28]  F. Perera,et al.  The common insecticides cyfluthrin and chlorpyrifos alter the expression of a subset of genes with diverse functions in primary human astrocytes. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  Michael C. Rosenstein,et al.  The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Ivan Ovcharenko,et al.  Predicting tissue-specific enhancers in the human genome. , 2006, Genome research.

[31]  D. Guay.  Update on fenofibrate. , 2006, Cardiovascular drug reviews.

[32]  J. McClintick,et al.  Global effects of vitamin A deficiency on gene expression in rat liver: evidence for hypoandrogenism. , 2006, The Journal of nutritional biochemistry.

[33]  T. Mendoza,et al.  Changes in Gene Expression Foreshadow Diet-Induced Obesity in Genetically Identical Mice , 2006, PLoS Genetics.

[34]  M. Gillum,et al.  Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.

[35]  M. You,et al.  Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide , 2006, Molecular Cancer Therapeutics.

[36]  Stylianos E. Antonarakis,et al.  Mendelian disorders deserve more attention , 2006, Nature Reviews Genetics.

[37]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[38]  M. Khoury,et al.  Genomics and Public Health in the United States: Signposts on the Translation Highway , 2006, Public Health Genomics.

[39]  Andrew C. Li,et al.  Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. , 2006, Annual review of pharmacology and toxicology.

[40]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[41]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[42]  Michael Lehrke,et al.  The Many Faces of PPARγ , 2005, Cell.

[43]  Eric E. Schadt,et al.  Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice , 2005, Nature.

[44]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. B. Allison,et al.  Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes , 2005, Diabetologia.

[46]  Shankar Subramaniam,et al.  Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes , 2004, Bioinform..

[47]  K. Kaestner,et al.  Foxl1 null mice have abnormal intestinal epithelia, postnatal growth retardation, and defective intestinal glucose uptake. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[48]  François Guillemot,et al.  A screen for downstream effectors of Neurogenin2 in the embryonic neocortex. , 2004, Developmental biology.

[49]  K. Iwamoto,et al.  Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders , 2004, Molecular Psychiatry.

[50]  N. Campbell.  Genetic association database , 2004, Nature Reviews Genetics.

[51]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[52]  Robert J Kavlock,et al.  Uncertainties for endocrine disrupters: our view on progress. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  S. Nishikawa,et al.  Mesenchymal expression of Foxl1, a winged helix transcriptional factor, regulates generation and maintenance of gut-associated lymphoid organs. , 2003, Developmental biology.

[54]  S. Beaulieu,et al.  Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. , 2002, Pharmacopsychiatry.

[55]  A. Cassard-Doulcier,et al.  A new polymorphic site located in the human UCP1 gene controls the in vitro binding of CREB-like factor , 2002, International Journal of Obesity.

[56]  D. Sinnett,et al.  Risk of childhood leukemia associated with diagnostic irradiation and polymorphisms in DNA repair genes. , 2000, Environmental health perspectives.

[57]  I. Skerjanc,et al.  Myocyte enhancer factor 2C upregulates MASH‐1 expression and induces neurogenesis in P19 cells , 2000, FEBS letters.

[58]  D. Labuda,et al.  Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. , 1999, Epidemiology.

[59]  M. Milburn.  0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL , 1999 .

[60]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[62]  J. Isaacsohn,et al.  Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. , 1996, JAMA.

[63]  Rf Power,et al.  Dopamine activation of an orphan of the steroid receptor superfamily , 1991, Science.

[64]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[65]  G. Parmigiani,et al.  Design and analysis issues in genome-wide somatic mutation studies of cancer. , 2009, Genomics.

[66]  E. Ponce,et al.  World Cancer Research Fund, American Institute for Cancer Research. Second Expert Report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. United Kingdom: WCRF/AICR, 2001 , 2009 .

[67]  J. Gregg,et al.  Gene expression changes in children with autism. , 2008, Genomics.

[68]  E. Jazin,et al.  BMC Psychiatry BioMed Central Research article Inflammation-related genes up-regulated in schizophrenia brains , 2007 .

[69]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[70]  廣畑 富雄,et al.  Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .

[71]  C. Burt,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.

[72]  K. Clément,et al.  Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. , 2006, BJOG : an international journal of obstetrics and gynaecology.

[73]  A. Butte,et al.  Creation and implications of a phenome-genome network , 2006, Nature Biotechnology.

[74]  J. Stockman.  The Rising Incidence of Childhood Type 1 Diabetes and Reduced Contribution of High-Risk HLA Haplotypes , 2006 .

[75]  S. Kleeberger,et al.  Gene-environment interactions in asthma and other respiratory diseases. , 2005, Annual review of medicine.

[76]  C. Burt,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999--2000. , 2004, Vital and health statistics. Series 13, Data from the National Health Survey.

[77]  NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di-n-Hexyl Phthalate (DnHP). , 2003, NTP CERHR MON.

[78]  J. Lehmann,et al.  A peroxisome proliferator-activated receptor g ligand inhibits adipocyte differentiation , 1999 .

[79]  S. Schappert.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996. , 1998, Vital and health statistics. Series 13, Data from the National Health Survey.

[80]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[81]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.